Mark H. Norman

Person

Thousand Oaks, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhib...
- Patent number 9,550,762
- Issue date Jan 24, 2017
- Amgen, Inc.
- Jennifer R. Allen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Amides as pim inhibitors
- Patent number 9,394,297
- Issue date Jul 19, 2016
- Amgen Inc.
- Victor Cee
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fused heterocyclic derivatives and methods of use
- Patent number 9,066,954
- Issue date Jun 30, 2015
- Amgen Inc.
- Brian K. Albrecht
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibitors of PI3 kinase and/or mTOR
- Patent number 8,772,480
- Issue date Jul 8, 2014
- Amgen Inc.
- Kristin L. Andrews
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of PI3 kinase
- Patent number 8,729,074
- Issue date May 20, 2014
- Amgen Inc.
- Yunxin Y. Bo
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Method of treating cancer with substituted amide derivatives
- Patent number 8,685,983
- Issue date Apr 1, 2014
- Amgen Inc.
- Tae-Seong Kim
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fused heterocyclic derivatives and methods of use
- Patent number 8,524,900
- Issue date Sep 3, 2013
- Amgen Inc.
- Brian K. Albrecht
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
TRP-M8 receptor ligands and their use in treatments
- Patent number 8,476,297
- Issue date Jul 2, 2013
- Amgen Inc.
- Mark H. Norman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds that interact with glucokinase regulatory protein for the...
- Patent number 8,431,563
- Issue date Apr 30, 2013
- Amgen Inc.
- Kate Ashton
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of PI3 kinase
- Patent number 8,415,376
- Issue date Apr 9, 2013
- Amgen Inc.
- Yunxin Y. Bo
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of PI3 kinase and/or mTOR
- Patent number 8,362,241
- Issue date Jan 29, 2013
- Amgen Inc.
- Noel D'Angelo
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Nitrogen-containing heterocyclyl ketones and methods of use
- Patent number 8,314,087
- Issue date Nov 20, 2012
- Amgen Inc.
- Brian K. Albrecht
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Vanilloid receptor ligands and their use in treatments
- Patent number 8,227,469
- Issue date Jul 24, 2012
- Amgen Inc.
- Chenera Balan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted amide derivatives and methods of use
- Patent number 8,088,794
- Issue date Jan 3, 2012
- Amgen Inc.
- Tae-Seong Kim
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Vanilloid receptor ligands and their use in treatments
- Patent number 8,026,241
- Issue date Sep 27, 2011
- Amgen Inc.
- Chenera Balan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Benzothiazole PI3 kinase modulators for cancer treatment
- Patent number 7,928,140
- Issue date Apr 19, 2011
- Amgen Inc.
- Shon Booker
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted heterocycles and methods of use
- Patent number 7,915,287
- Issue date Mar 29, 2011
- Amgen Inc.
- Steven Bellon
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Imidazopyridazine inhibitors of PI3 kinase for cancer treatment
- Patent number 7,820,665
- Issue date Oct 26, 2010
- Amgen Inc.
- Shon Booker
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Vanilloid receptor ligands and their use in treatments
- Patent number 7,709,501
- Issue date May 4, 2010
- Amgen Inc.
- Ning Chen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted pyridines and pyrimidines and their use in treatment of...
- Patent number 7,687,522
- Issue date Mar 30, 2010
- Amgen Inc.
- Steven Bellon
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Vanilloid receptor ligands and their use in treatments
- Patent number 7,582,761
- Issue date Sep 1, 2009
- Amgen Inc.
- Chenera Balan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Vanilloid receptor ligands and their use in treatments
- Patent number 7,579,347
- Issue date Aug 25, 2009
- Amgen Inc.
- Yunxin Y. Bo
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted piperazines and methods of use
- Patent number 7,560,460
- Issue date Jul 14, 2009
- Amgen Inc.
- Christopher H. Fotsch
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Vanilloid receptor ligands and their use in treatments
- Patent number 7,553,848
- Issue date Jun 30, 2009
- Amgen Inc.
- Christopher Hulme
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Vanilloid receptor ligands and their use in treatments
- Patent number 7,544,803
- Issue date Jun 9, 2009
- Amgen Inc.
- Christopher Hulme
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Vanilloid receptor ligands and their use in treatments
- Patent number 7,534,798
- Issue date May 19, 2009
- Amgen Inc.
- Chenera Balan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Vanilloid receptor ligands and their use in treatments
- Patent number 7,524,874
- Issue date Apr 28, 2009
- Amgen Inc.
- Elizabeth M. Doherty
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Vanilloid receptor ligands and their use in treatments
- Patent number 7,511,044
- Issue date Mar 31, 2009
- Amgen Inc.
- Hui-Ling Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
N-linked sulfonamides of N-heterocyclic carboxylic acids or carboxy...
- Patent number 7,459,473
- Issue date Dec 2, 2008
- Glia Med, Inc.
- Gregory S. Hamilton
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Vanilloid receptor ligands and their use in treatments
- Patent number 7,439,360
- Issue date Oct 21, 2008
- Amgen Inc.
- Vijay Keshav Gore
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
CYCLOPROPYL FUSED THIAZIN-2-AMINE COMPOUNDS AS BETA-SECRETASE INHIB...
- Publication number 20170267673
- Publication date Sep 21, 2017
- Amgen Inc.
- Jennifer R. ALLEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Cyclopropyl Fused Thiazin-2-Amine Compounds as Beta-Secretase Inhib...
- Publication number 20160046618
- Publication date Feb 18, 2016
- Amgen Inc.
- Jennifer R. ALLEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
AMIDES AS PIM INHIBITORS
- Publication number 20150329538
- Publication date Nov 19, 2015
- Amgen Inc.
- Victor CEE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BENZODIOXEPINE AND BENZODIOXINE COMPOUNDS THAT INTERACT WITH GLUCOK...
- Publication number 20140155415
- Publication date Jun 5, 2014
- Michael David Bartberger
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FUSED HETEROCYCLIC DERIVATIVES AND METHODS OF USE
- Publication number 20130303529
- Publication date Nov 14, 2013
- Brian K. ALBRECHT
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Inhibitors of PI3 Kinase and/or mTOR
- Publication number 20130079303
- Publication date Mar 28, 2013
- Amgen Inc.
- Kristin L. ANDREWS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE...
- Publication number 20120225854
- Publication date Sep 6, 2012
- Amgen Inc.
- Kate Ashton
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Heteroaryl Compounds as PIKK Inhibitors
- Publication number 20120190666
- Publication date Jul 26, 2012
- Amgen Inc.
- Christiane Bode
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FUSED HETEROCYCLIC DERIVATIVES AND METHODS OF USE
- Publication number 20120148531
- Publication date Jun 14, 2012
- Amgen Inc.
- Brian K. Albrecht
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FUSED HETEROCYCLIC DERIVATIVES AND METHODS OF USE
- Publication number 20120107275
- Publication date May 3, 2012
- Amgen Inc.
- Brian K. Albrecht
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF PI3 KINASE
- Publication number 20120071474
- Publication date Mar 22, 2012
- Amgen Inc.
- Yunxin Y. Bo
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHOD OF TREATING CANCER WITH SUBSTITUTED AMIDE DERIVATIVES
- Publication number 20120070413
- Publication date Mar 22, 2012
- Tae-Seong KIM
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED AMIDE DERIVATIVES AND METHODS OF USE
- Publication number 20110118252
- Publication date May 19, 2011
- Amgen Inc.
- Tae-Seong Kim
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF PI3 KINASE
- Publication number 20110092504
- Publication date Apr 21, 2011
- Amgen Inc.
- Yunxin Y. Bo
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF PI3 KINASE AND/OR MTOR
- Publication number 20100273764
- Publication date Oct 28, 2010
- Amgen Inc.
- Kristin Andrews
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TRP-M8 RECEPTOR LIGANDS AND THEIR USE IN TREATMENTS
- Publication number 20100261728
- Publication date Oct 14, 2010
- Amgen Inc.
- Mark H. Norman
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Fused heterocyclic derivatives and methods of use
- Publication number 20090318436
- Publication date Dec 24, 2009
- Amgen Inc.
- Brian K. Albrecht
- C07 - ORGANIC CHEMISTRY
Information Patent Application
VANILLOID RECEPTOR LIGANDS AND THEIR USE IN TREATMENTS
- Publication number 20090264424
- Publication date Oct 22, 2009
- Amgen Inc.
- Yunxin Y. Bo
- C07 - ORGANIC CHEMISTRY
Information Patent Application
VANILLOID RECEPTOR LIGANDS AND THEIR USE IN TREATMENTS
- Publication number 20090197879
- Publication date Aug 6, 2009
- Chenera Balan
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Inhibitors of PI3 kinase
- Publication number 20090163489
- Publication date Jun 25, 2009
- Shon Booker
- C07 - ORGANIC CHEMISTRY
Information Patent Application
VANILLOID RECEPTOR LIGANDS AND THEIR USE IN TREATMENTS
- Publication number 20090143575
- Publication date Jun 4, 2009
- Chenera Balan
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Fused heterocyclic derivatives and methods of use
- Publication number 20090124609
- Publication date May 14, 2009
- Amgen Inc.
- Brian K. Albrecht
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Fused heterocyclic derivatives and methods of use
- Publication number 20090124612
- Publication date May 14, 2009
- Amgen Inc.
- Brian K. Albrecht
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Vanilloid receptor ligands and their use in treatments
- Publication number 20090082358
- Publication date Mar 26, 2009
- Nobuko Nishimura
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PI3 kinase modulators and methods of use
- Publication number 20090054405
- Publication date Feb 26, 2009
- Amgen Inc.
- Shon Booker
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Substituted amide derivatives and methods of use
- Publication number 20080312232
- Publication date Dec 18, 2008
- Amgen Inc.
- Tae-Seong Kim
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Nitrogen-Containing heterocyclyl ketones and methods of use
- Publication number 20080280917
- Publication date Nov 13, 2008
- Amgen Inc.
- Brian K. Albrecht
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Substituted heterocycles and methods of use
- Publication number 20080214544
- Publication date Sep 4, 2008
- Amgen Inc.
- Steven Bellon
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Substituted heterocycles and methods of use
- Publication number 20080200464
- Publication date Aug 21, 2008
- Amgen Inc.
- Steven Bellon
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Substituted piperazines and methods of use
- Publication number 20070265248
- Publication date Nov 15, 2007
- Amgen Inc.
- Christopher H. Fotsch
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Mark H. Norman

Person

Patents Grantslast 30 patents

Cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhib...

Amides as pim inhibitors

Fused heterocyclic derivatives and methods of use

Inhibitors of PI3 kinase and/or mTOR

Inhibitors of PI3 kinase

Method of treating cancer with substituted amide derivatives

Fused heterocyclic derivatives and methods of use

TRP-M8 receptor ligands and their use in treatments

Compounds that interact with glucokinase regulatory protein for the...

Inhibitors of PI3 kinase

Inhibitors of PI3 kinase and/or mTOR

Nitrogen-containing heterocyclyl ketones and methods of use

Vanilloid receptor ligands and their use in treatments

Substituted amide derivatives and methods of use

Vanilloid receptor ligands and their use in treatments

Benzothiazole PI3 kinase modulators for cancer treatment

Substituted heterocycles and methods of use

Imidazopyridazine inhibitors of PI3 kinase for cancer treatment

Vanilloid receptor ligands and their use in treatments

Substituted pyridines and pyrimidines and their use in treatment of...

Vanilloid receptor ligands and their use in treatments

Vanilloid receptor ligands and their use in treatments

Substituted piperazines and methods of use

Vanilloid receptor ligands and their use in treatments

Vanilloid receptor ligands and their use in treatments

Vanilloid receptor ligands and their use in treatments

Vanilloid receptor ligands and their use in treatments

Vanilloid receptor ligands and their use in treatments

N-linked sulfonamides of N-heterocyclic carboxylic acids or carboxy...

Vanilloid receptor ligands and their use in treatments

Patents Applicationslast 30 patents

CYCLOPROPYL FUSED THIAZIN-2-AMINE COMPOUNDS AS BETA-SECRETASE INHIB...

Cyclopropyl Fused Thiazin-2-Amine Compounds as Beta-Secretase Inhib...

AMIDES AS PIM INHIBITORS

BENZODIOXEPINE AND BENZODIOXINE COMPOUNDS THAT INTERACT WITH GLUCOK...

FUSED HETEROCYCLIC DERIVATIVES AND METHODS OF USE

Inhibitors of PI3 Kinase and/or mTOR

COMPOUNDS THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE...

Heteroaryl Compounds as PIKK Inhibitors

FUSED HETEROCYCLIC DERIVATIVES AND METHODS OF USE

FUSED HETEROCYCLIC DERIVATIVES AND METHODS OF USE

INHIBITORS OF PI3 KINASE

METHOD OF TREATING CANCER WITH SUBSTITUTED AMIDE DERIVATIVES

SUBSTITUTED AMIDE DERIVATIVES AND METHODS OF USE

INHIBITORS OF PI3 KINASE

INHIBITORS OF PI3 KINASE AND/OR MTOR

TRP-M8 RECEPTOR LIGANDS AND THEIR USE IN TREATMENTS

Fused heterocyclic derivatives and methods of use

VANILLOID RECEPTOR LIGANDS AND THEIR USE IN TREATMENTS

VANILLOID RECEPTOR LIGANDS AND THEIR USE IN TREATMENTS

Inhibitors of PI3 kinase

VANILLOID RECEPTOR LIGANDS AND THEIR USE IN TREATMENTS

Fused heterocyclic derivatives and methods of use

Fused heterocyclic derivatives and methods of use

Vanilloid receptor ligands and their use in treatments

PI3 kinase modulators and methods of use

Substituted amide derivatives and methods of use

Nitrogen-Containing heterocyclyl ketones and methods of use

Substituted heterocycles and methods of use

Substituted heterocycles and methods of use

Substituted piperazines and methods of use